Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
Time to combine innovation, access and technology to deliver positive patient outcomes
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Twelve hospitals across India will be part of the network which will support the trial in India
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
With the recent sales force expansion and new product launches, we expect to be back to above-market growth
A pharma industry veteran with over three decades of experience in domestic as well as international markets
Subscribe To Our Newsletter & Stay Updated
